secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001641172-25-006201
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel increases authorized common shares from 250M to 600M; removes Series E conversion cap
--------------------------------------------------------------------------------

- Board and majority stockholder approved Certificate of Amendment filed April 25, 2025.
- Authorized common stock increased from 250,000,000 to 600,000,000 shares; no change to issued shares.
- Amended Series E Certificate of Designation removes the 4.99% ownership limitation on conversion and voting.
- Removal of Series E cap allows unlimited conversion of preferred into common shares going forward.
- Both amendments effective upon filing with Delaware Secretary of State on April 25, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225006201/0001641172-25-006201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225006201/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-006201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer